z-logo
Premium
Successful treatment of a disseminated infection with extensively drug‐resistant K lebsiella pneumoniae in a liver transplant recipient with a fosfomycin‐based multidrug regimen
Author(s) -
Mills J.P.,
Wilck M.B.,
Weikert B.C.,
Porrett P.M.,
Timko D.,
Alby K.,
Bonomo R.A.,
Blumberg E.A.
Publication year - 2016
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12578
Subject(s) - fosfomycin , medicine , colistin , multiple drug resistance , regimen , antibiotics , adjunctive treatment , drug , drug resistance , klebsiella pneumoniae , microbiology and biotechnology , pharmacology , biology , biochemistry , escherichia coli , gene
Donor‐derived infections with multidrug‐resistant gram‐negative bacteria are associated with poor outcomes, in part because of limited treatment options. Here, we describe a case of donor‐derived, disseminated infection with colistin‐resistant, carbapenemase‐producing K lebsiella pneumoniae in a liver transplant recipient that was cured with addition of intravenous fosfomycin to a multidrug regimen, in conjunction with aggressive surgical source control. Intravenous fosfomycin represents a promising adjunctive agent for use in treatment of extensively drug‐resistant infections in immunocompromised hosts.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here